Filing Details

Accession Number:
0001209191-18-005204
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-24 17:33:22
Reporting Period:
2018-01-22
Accepted Time:
2018-01-24 17:33:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1446372 M Paul Silva C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp & Corp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-22 2,427 $86.52 19,061 No 4 M Direct
Common Stock Disposition 2018-01-22 2,427 $161.52 16,634 No 4 S Direct
Common Stock Acquisiton 2018-01-23 1,289 $91.05 17,923 No 4 M Direct
Common Stock Acquisiton 2018-01-23 1,719 $90.29 19,642 No 4 M Direct
Common Stock Disposition 2018-01-23 3,008 $166.05 16,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-01-22 2,427 $0.00 2,427 $86.52
Common Stock Stock Option (Right to Buy) Disposition 2018-01-23 1,289 $0.00 1,289 $91.05
Common Stock Stock Option (Right to Buy) Disposition 2018-01-23 1,719 $0.00 1,719 $90.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,517 2027-02-02 No 4 M Direct
11,602 2026-02-01 No 4 M Direct
8,594 2026-07-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 169 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 2/3/2017.
  3. The option vests in 16 quarterly installments from 2/2/2016.
  4. The option vests in 16 quarterly installments from 7/12/2016.